Tamar Sofer1,2, Jee-Young Moon3, Carmen R Isasi3, Qibin Qi3, Neomi A Shah4, Robert C Kaplan3,5, Mark H Kuniholm6. 1. Department of Medicine, Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Boston, MA, USA. 2. Department of Medicine, Harvard Medical School, Boston, MA, USA. 3. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA. 4. Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 5. Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. 6. Department of Epidemiology and Biostatistics, University at Albany, State University of New York, Rensselaer, NY, USA.
Abstract
Background: Associations of adult height with cardiometabolic and pulmonary traits have been studied in majority European ancestry populations using Mendelian randomization and polygenic risk score (PRS) analysis. The standard PRS approach entails creating a PRS for height using variants identified in prior genome-wide association studies (GWAS). It is unclear how well the standard PRS approach performs in non-European populations and whether height-trait associations observed in Europeans are also observed in other populations. Methods: In the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), we used: (i) the standard approach to create a PRS for height (PRS1) and (ii) a novel approach to optimize the selection of variants from previously established height association loci to better explain height in HCHS/SOL (PRS2). We also estimated the extent to which PRS-trait associations were independent or mediated by the PRS effect on height. Results: In 7539 women and 5245 men, PRS1 and PRS2 explained 9 and 29% of the variance in measured height, respectively. Both PRS1 and PRS2 were associated with forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), FEV1/ FVC ratio, total cholesterol and 2-hour oral glucose-tolerance test insulin levels. Additionally, PRS2 was associated with estimated glomerular filtration rate and ankle brachial index. Both PRS1 and PRS2 had pleiotropic associations with FEV1/ FVC ratio in mediation analyses. Conclusions: Associations of polygenic scores of height with measures of lung function and cholesterol were consistent with those observed in prior studies of majority European ancestry populations. Mediation analysis may augment standard PRS approaches to disentangle pleiotropic and mediated effects.
Background: Associations of adult height with cardiometabolic and pulmonary traits have been studied in majority European ancestry populations using Mendelian randomization and polygenic risk score (PRS) analysis. The standard PRS approach entails creating a PRS for height using variants identified in prior genome-wide association studies (GWAS). It is unclear how well the standard PRS approach performs in non-European populations and whether height-trait associations observed in Europeans are also observed in other populations. Methods: In the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), we used: (i) the standard approach to create a PRS for height (PRS1) and (ii) a novel approach to optimize the selection of variants from previously established height association loci to better explain height in HCHS/SOL (PRS2). We also estimated the extent to which PRS-trait associations were independent or mediated by the PRS effect on height. Results: In 7539 women and 5245 men, PRS1 and PRS2 explained 9 and 29% of the variance in measured height, respectively. Both PRS1 and PRS2 were associated with forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), FEV1/ FVC ratio, total cholesterol and 2-hour oral glucose-tolerance test insulin levels. Additionally, PRS2 was associated with estimated glomerular filtration rate and ankle brachial index. Both PRS1 and PRS2 had pleiotropic associations with FEV1/ FVC ratio in mediation analyses. Conclusions: Associations of polygenic scores of height with measures of lung function and cholesterol were consistent with those observed in prior studies of majority European ancestry populations. Mediation analysis may augment standard PRS approaches to disentangle pleiotropic and mediated effects.
Authors: Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey Journal: N Engl J Med Date: 2012-07-05 Impact factor: 91.245
Authors: Paul D Sorlie; Larissa M Avilés-Santa; Sylvia Wassertheil-Smoller; Robert C Kaplan; Martha L Daviglus; Aida L Giachello; Neil Schneiderman; Leopoldo Raij; Gregory Talavera; Matthew Allison; Lisa Lavange; Lloyd E Chambless; Gerardo Heiss Journal: Ann Epidemiol Date: 2010-08 Impact factor: 3.797
Authors: Karri Silventoinen; Slobodan Zdravkovic; Axel Skytthe; Peter McCarron; Anne Maria Herskind; Markku Koskenvuo; Ulf de Faire; Nancy Pedersen; Kaare Christensen; Jaakko Kaprio Journal: Am J Epidemiol Date: 2006-02-16 Impact factor: 4.897
Authors: Eveline Nüesch; Caroline Dale; Tom M Palmer; Jon White; Brendan J Keating; Erik Pa van Iperen; Anuj Goel; Sandosh Padmanabhan; Folkert W Asselbergs; W M Verschuren; C Wijmenga; Y T Van der Schouw; N C Onland-Moret; Leslie A Lange; G K Hovingh; Suthesh Sivapalaratnam; Richard W Morris; Peter H Whincup; Goya S Wannamethe; Tom R Gaunt; Shah Ebrahim; Laura Steel; Nikhil Nair; Alexander P Reiner; Charles Kooperberg; James F Wilson; Jennifer L Bolton; Stela McLachlan; Jacqueline F Price; Mark Wj Strachan; Christine M Robertson; Marcus E Kleber; Graciela Delgado; Winfried März; Olle Melander; Anna F Dominiczak; Martin Farrall; Hugh Watkins; Maarten Leusink; Anke H Maitland-van der Zee; Mark Ch de Groot; Frank Dudbridge; Aroon Hingorani; Yoav Ben-Shlomo; Debbie A Lawlor; A Amuzu; M Caufield; A Cavadino; J Cooper; T L Davies; F Drenos; J Engmann; C Finan; C Giambartolomei; R Hardy; S E Humphries; E Hypponen; M Kivimaki; D Kuh; M Kumari; K Ong; V Plagnol; C Power; M Richards; S Shah; T Shah; R Sofat; P J Talmud; N Wareham; H Warren; J C Whittaker; A Wong; D Zabaneh; George Davey Smith; Jonathan C Wells; David A Leon; Michael V Holmes; Juan P Casas Journal: Int J Epidemiol Date: 2016-12-01 Impact factor: 7.196
Authors: Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean Journal: Nature Date: 2012-11-01 Impact factor: 49.962
Authors: Sridharan Raghavan; Jie Huang; Catherine Tcheandjieu; Jennifer E Huffman; Elizabeth Litkowski; Chang Liu; Yuk-Lam A Ho; Haley Hunter-Zinck; Hongyu Zhao; Eirini Marouli; Kari E North; Ethan Lange; Leslie A Lange; Benjamin F Voight; J Michael Gaziano; Saiju Pyarajan; Elizabeth R Hauser; Philip S Tsao; Peter W F Wilson; Kyong-Mi Chang; Kelly Cho; Christopher J O'Donnell; Yan V Sun; Themistocles L Assimes Journal: PLoS Genet Date: 2022-06-02 Impact factor: 6.020
Authors: Eirini Marouli; M Fabiola Del Greco; Christina M Astley; Jian Yang; Shafqat Ahmad; Sonja I Berndt; Mark J Caulfield; Evangelos Evangelou; Barbara McKnight; Carolina Medina-Gomez; Jana V van Vliet-Ostaptchouk; Helen R Warren; Zhihong Zhu; Joel N Hirschhorn; Ruth J F Loos; Zoltan Kutalik; Panos Deloukas Journal: Commun Biol Date: 2019-03-27
Authors: Cristin E McArdle; Hassan Bokhari; Clinton C Rodell; Victoria Buchanan; Liana K Preudhomme; Carmen R Isasi; Mariaelisa Graff; Kari North; Linda C Gallo; Amber Pirzada; Martha L Daviglus; Genevieve Wojcik; Jianwen Cai; Krista Perreira; Lindsay Fernandez-Rhodes Journal: Front Genet Date: 2021-12-06 Impact factor: 4.599